Key Takeover Interest and Deal Risk Signals for Mattel (NASDAQ:MAT)

  • Mattel (NASDAQ:MAT) shares rallied about 18% on October 1, 2026 after a newspaper reported Authentic Brands Group interest at more than USD 20 a share; no formal offer has been confirmed by the company.
  • Medtronic (NYSE:MDT) announced on October 7, 2026 a final exchange ratio of 4.5939 MiniMed shares per Medtronic share, the upper limit, in a split-off offer that expires at midnight New York time on October 9.
  • Skydance (NYSE:SKYD) traded down about 8% midday on October 7, 2026 at USD 8.77, one day after closing its Warner Bros. Discovery acquisition, with about USD 80 billion of combined debt.
  • McDonald's (NYSE:MCD) faces a proposed federal class action in Illinois, reported on October 6, 2026, alleging its AI-enhanced pricing tool amounts to algorithmic price-fixing across about 14,000 U.S. restaurants, which the company disputes.

IPO Timing and Valuation: Outlook Implications for Mattel (NASDAQ:MAT)

On October 1, 2026, a newspaper reported that Authentic Brands Group had approached Mattel about a takeover that could value the Barbie and Hot Wheels maker at about USD 6 billion or more, with discussions involving more than USD 20 per share. Simple arithmetic on two published numbers puts USD 20 about 58% above that close. According to A separate report on October 7, zuru has engaged bankers to consider a bid, which is unconfirmed, and the stock rose roughly 3.1% to 3.8% that day. Mattel (NASDAQ:MAT) closed up about 18% at roughly USD 15.04 to USD 15.10, from USD 12.66 the day before. Coverage stated there is no formal sale process and no announced offer, and the approach was described as preliminary. Southeastern Asset Management, holding more than 4%, urged the board on May 7, 2026 to explore strategic alternatives and saw value approaching USD 30 per share. Chief executive Ynon Kreiz stepped down on October 2, and director Roger Lynch takes over as CEO no later than November 2. Second quarter adjusted EPS fell to USD 0.01 from USD 0.21, and net Debt was USD 1,810.0 million at June 30. Risks include no bid materializing. Third quarter results are estimated for about October 20.

IPO Timing and Valuation: Key Business Impact on Skydance (NYSE:SKYD)

According to In a release at 5:31 p.m. ET on October 7, 2026, Medtronic (NYSE:MDT), the final exchange ratio is 4.5939 MiniMed shares for each Medtronic ordinary share accepted. The offer covers up to 225,361,295 MiniMed shares, or 80.1% of the company, and expires at midnight New York time on October 9 unless extended. Medtronic shares are valued at 100% of a three-day average price, while MiniMed shares are valued at 93%, a 7% discount. The calculated ratio would have exceeded the upper limit, so the limit applies. Medtronic holds 252,813,348 MiniMed shares, about 90%, after the March 2026 IPO at USD 20. The limit binds when MiniMed trades weakly. Simple arithmetic on one published number: 4.5939 shares at MiniMed's USD 19.14 close on October 7 equals about USD 87.93 of MiniMed stock per Medtronic share. MiniMed fell 17.8% over the past month. If oversubscribed, tendered shares would be prorated. The offer needs at least 112,680,647 MiniMed shares issued and a tax-free opinion. If undersubscribed, Medtronic would keep roughly 9.76% and plan a later transaction. Medtronic (NYSE:MDT) has not reported tender results, and its USD 0.72 Dividend is payable October 16, 2026.

Risks From Deal Debt and Leverage for Skydance (NYSE:SKYD)

Skydance, formerly Paramount Skydance, finished buying Warner Bros. Discovery on Tuesday, October 6, 2026, and its Class B shares began trading under SKYD on the New York Stock Exchange that day. On October 7, Skydance (NYSE:SKYD) was down 7.87% at USD 8.77 at 12:42 p.m. ET, with later readings between 6.95% and 8.24%, and the official close was not found. The mechanism is leverage. Warner Bros. Discovery holders received roughly USD 31.02 in cash per share. Reports put the deal value near USD 110 billion, though one headline cited USD 81 billion. The combined company carries approximately USD 80 billion of debt, and on October 1 it priced USD 41.4 billion of senior secured notes to fund the deal. Management targets net leverage of 3.0 times by the end of 2029, at least USD 6 billion of run-rate synergies within three years and more than USD 10 billion of free Cash Flow by 2030. Barclays kept an Underweight rating and cut its target to USD 7 from USD 8. Risks include execution on cost cuts, linear television contraction and refinancing costs. Note settlement is projected on October 9, and Skydance (NYSE:SKYD) has not announced its first combined Earnings date.

McDonald's (NYSE:MCD) After the Latest Company Update Update

A proposed class action was reported as filed in federal court in Illinois, around Friday, October 2, 2026, alleging McDonald's (NYSE:MCD) and its franchisees fixed prices using algorithms trained on nonpublic data, including store-level sales. It points to a roughly 40% menu price advance from 2019 to 2024 and seeks an injunction and damages, though no figure was reported. McDonald's calls the complaint filled with inaccuracies, states AI does not set menu prices, and states franchisees decide. The complaint covers about 14,000 U.S. restaurants, and franchisees own 95% of U.S. stores. The legal theory is that independent franchisees are competitors, so a shared pricing engine fed by their data can act as a hub that coordinates prices without a direct agreement, similar to the rent-software cases. The allegations are untested. The stock traded near USD 231.52 on October 7 in published market data, about 0.5% below USD 232.69 on October 6 and near its 52-week low of USD 229.20. It fell 4.8% on September 23, the day of its investor day. Wells Fargo cut its target to USD 270 from USD 300 on October 5. Watch for a motion to dismiss and the third quarter report, whose date McDonald's (NYSE:MCD) had not confirmed.

Key Items to Watch for Skydance (NYSE:SKYD): Takeover Interest and Deal Risk

Skydance (NYSE:SKYD) fell about 8% on October 7, 2026 largely because investors are weighing roughly USD 80 billion of debt against synergy targets that are still promises. Mattel (NASDAQ:MAT) is the subject of a reported, unconfirmed approach. McDonald's (NYSE:MCD) faces an early-stage lawsuit it disputes. The other three names show different corporate events. Medtronic (NYSE:MDT) has fixed a capped ratio and an offer that ends October 9. Most items are reported or in progress, so company statements and filings are the next checkpoints.